# Protara Therapeutics (TARA) — Earnings

TARA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/tara/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$0.31 |
| EPS estimate | −$0.38 |
| EPS surprise | +19.27% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Nov 10, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1359931/000121390025107881/ea0262733-10q_protara.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 10, 2025 | −$0.38 | −$0.31 | 19.27% | — | — |
| Q2 2025 | Aug 11, 2025 | −$0.39 | −$0.35 | 9.09% | — | — |
| Q1 2025 | May 8, 2025 | −$0.45 | −$0.29 | 35.81% | — | — |
| Q4 2024 | Mar 5, 2025 | −$0.57 | −$0.48 | 15.04% | — | — |
| Q3 2024 | Nov 12, 2024 | −$0.52 | −$0.50 | 3.85% | — | — |
| Q2 2024 | Aug 6, 2024 | −$0.80 | −$0.45 | 43.75% | — | — |
| Q1 2024 | May 2, 2024 | −$0.92 | −$0.97 | -5.43% | — | — |
| Q4 2023 | Mar 13, 2024 | −$0.92 | −$0.90 | 1.91% | — | — |
| Q3 2023 | Nov 3, 2023 | −$0.98 | −$0.87 | 11.22% | — | — |
| Q2 2023 | Aug 3, 2023 | −$0.88 | −$1.00 | -14.29% | — | — |
| Q1 2023 | May 4, 2023 | −$0.88 | −$0.80 | 8.75% | — | — |
| Q4 2022 | Mar 8, 2023 | −$0.75 | −$3.46 | -361.33% | — | — |
| Q3 2022 | Nov 3, 2022 | −$0.76 | −$0.68 | 10.14% | — | — |
| Q2 2022 | Aug 9, 2022 | −$0.94 | −$0.80 | 14.59% | — | — |
| Q1 2022 | May 5, 2022 | −$0.90 | −$0.96 | -6.28% | — | — |
| Q4 2021 | Mar 9, 2022 | −$0.94 | −$0.91 | 3.53% | — | — |
| Q3 2021 | Nov 4, 2021 | −$1.01 | −$0.96 | 4.95% | — | — |
| Q2 2021 | Aug 5, 2021 | −$1.05 | −$1.14 | -8.31% | — | — |
| Q1 2021 | May 6, 2021 | −$0.73 | −$1.20 | -65.13% | — | — |
| Q4 2020 | Mar 11, 2021 | −$0.54 | −$0.79 | -45.41% | — | — |

## Frequently Asked Questions

### When did Protara Therapeutics (TARA) last report earnings?

Protara Therapeutics last reported on Nov 10, 2025, covering fiscal Q3 2025.

### Did TARA beat earnings estimates?

Yes. Protara Therapeutics reported EPS of −$0.31 for Q3 2025 against a −$0.38 estimate — a 19.27% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).